Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kenvue Inc

23.19
+0.92004.13%
Pre-market: 23.200.0100+0.04%08:17 EDT
Volume:25.92M
Turnover:598.01M
Market Cap:44.49B
PE:43.12
High:23.23
Open:22.56
Low:22.44
Close:22.27
Loading ...

Kenvue Inc - Board to Temporarily Expand to 14 Directors, Reduce to 13 in 2025

THOMSON REUTERS
·
05 Mar

Kenvue Inc - Starboard Agrees to Customary Standstill Provisions

THOMSON REUTERS
·
05 Mar

Kenvue Announces Three New Appointments to Board of Directors

Business Wire
·
05 Mar

BRIEF-Kenvue Settles Proxy Fight With Activist Starboard - CNBC

Reuters
·
05 Mar

Kenvue Settles Proxy Fight With Activist Starboard, Sources Tell CNBC

THOMSON REUTERS
·
05 Mar

Canaccord Genuity Adjusts Price Target on Kenvue to $29 From $24, Maintains Buy Rating

MT Newswires Live
·
05 Mar

Kenvue Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
05 Mar

Kenvue Inc.'s (NYSE:KVUE) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Simply Wall St.
·
02 Mar

Kenvue Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
01 Mar

BRIEF-Kenvue Files For Mixed Shelf Offering Size Not Disclosed - SEC Filing

Reuters
·
25 Feb

Kenvue Inc Files for Mixed Shelf Offering; Size Not Disclosed- SEC Filing

THOMSON REUTERS
·
25 Feb

Piper Sandler Adjusts Price Target on Kenvue to $27 From $24, Keeps Overweight Rating

MT Newswires Live
·
24 Feb

Kenvue Is Maintained at Overweight by Piper Sandler

Dow Jones
·
24 Feb

U.S. RESEARCH ROUNDUP-Amneal pharma, Aramark, Bluebird Bio

Reuters
·
24 Feb

Is Kenvue Inc. (KVUE) the Best Spin Off Stock to Buy According to Hedge Funds?

Insider Monkey
·
22 Feb

Market Today: UnitedHealth Faces DOJ Probe, Novo Nordisk Resolves Drug Shortage

GuruFocus
·
22 Feb

Kenvue Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
22 Feb

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EST

Reuters
·
22 Feb

Barclays Sticks to Their Hold Rating for Kenvue, Inc. (KVUE)

TIPRANKS
·
20 Feb

Kenvue Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
20 Feb